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3Abstract. – OBJECTIVE: Obstructive sleep 
apnea (OSA) is the primary indication for tonsil-
lectomy, one of the most common pediatric sur-
gical procedures, commonly performed in as-
sociation with adenoidectomy. The objective of 
this review article is to evaluate the role of the 
otorhinolaryngologist in pediatric OSA.
MATERIALS AND METHODS: A literature 
review has been performed on the following 
topics: peculiarities of sleep-disordered breath-
ing in pediatric age; discrimination of sleep 
disorders; adenotonsillar hypertrophy; surgical 
techniques; adjuvant surgical procedures.
RESULTS: The role of the otorhinolaryngolo-
gist in pediatric OSA is important for the eval-
uation of the upper airways and of essential 
biometric and polysomnographic data and for 
indication and execution of appropriate surgical 
treatment. In the majority of healthy children, 
adenotonsillectomy for OSA results in a dra-
matic improvement in respiratory parameters as 
measured by polysomnography. When post-sur-
gical residual OSA occurs, it is essential to mon-
itor patients by means of drug-induced sleep 
endoscopy (DISE).
CONCLUSIONS: Otolaryngologic assessment 
is of paramount importance to correctly classi-
fy a child with OSA. Correct inspection of the 
upper airway and quantification of the quality 
of sleep through polysomnography lead to the 
right therapeutic choice. Knowledge of different 
surgical techniques helps to deal with residu-
al OSA after studying the obstruction sites by 
drug-induced sedation endoscopy.
Key Words
Obstructive sleep apnea, Cardio-respiratory moni-
toring, Drug-induced sleep endoscopy.
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OSA: obstructive sleep apnea; SDB: sleep-disordered 
breathing; REM: rapid eye movement; PSG: polysom-
nography; UARS: Upper Airway Resistance Syndrome; 
DISE: drug-induced sedation endoscopy; AHI: apnea 
hypopnea index; VOTE: Velum oropharynx tongue base 
epiglottis; NOHL: Nose Oropharynx Hypopharynx and 
Larynx; post-AT: after adenotonsillectomy.
Introduction
In the management of the child with obstruc-
tive obstructive sleep apnea (OSA) and, more 
broadly, sleep-disordered breathing (SDB), the 
role of the otorhinolaryngologist is to provide 
the right indication and execution of the surgi-
cal procedure. In choosing the surgical proce-
dure, possible complication factors must always 
be evaluated. These do not usually occur during 
the execution of the surgery; risk factors identi-
fied in the preoperative phase help predict likely 
postoperative complications, and thus inform sur-
gical strategy1. Genesis of SDB is multifactorial. 
Among the most common causes, we consider 
adenotonsillar hypertrophy (45-50%) and obesity 
(35-45%) as being the main causes for a reduction 
in pharynx size. Furthermore, obesity also deter-
mines a reduction in the tone of the muscles locat-
ed in the lateral walls of the pharynx. Other caus-
es may include craniofacial malformations (e.g. 
micrognathia) and upper airway abnormalities 
(e.g. glossoptosis). A third cause, which seldom 
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occurs in association with the previous ones, is 
the presence of neuromuscular diseases that lead 
to a lack of upper airway control mechanisms. For 
these reasons, the diagnostic approach and thera-
peutic planning should involve several specialists 
1-5. Peculiarities of SDB in pediatric age include 
higher frequency of “obstructive hypoventilation” 
instead of periodic and distinct apneic events; 
poor correlation between clinical picture severity, 
daytime symptomatology and objective picture; 
daytime hyperactivity rather than sleepiness; 
normal sleep architecture compared to the sleep 
fragmentation observed in adults; and obstructive 
apnea observed only in the rapid eye movement 
(REM) phase 1-5. Comorbidities can be present 
although they are more common in the adult pop-
ulation 6. The broad term SDB also encompasses 
non-obstructive causes of sleep-related breathing 
disorders, such as sleep-related hypoventilation 
disorders and central sleep apnea syndromes. For 
example, the term “obstructive SDB” may include 
a child who snores and has hyperactive behaviors 
during the day, but his or her polysomnography 
(PSG) does not show OSA. Guilleminault et al7 
first described the increased Upper Airway Re-
sistance Syndrome (UARS), having observed 
in some children a higher respiratory effort due 
to an increase in upper airway resistance. This 
condition is not associated with apneic episodes 
or pathological desaturations but only with flow 
limitations and microarousals. The clinical con-
sequences of this syndrome, due to an increased 
muscular effort demanding excessive energy, are 
evidenced by insufficient weight growth (due to 
a reduction of the growth hormone secretion in 
sleep phase four), poor school performance, and 
daytime irritability. It is important to remember 
that the diagnosis of UARS may not be detected 
via PSG because of the lack of apnea and periods 
of hypoxemia. Diagnosis of UARS is based rather 
on clinical suspicion deriving from the evidence 
of flow limitations and microarousals, as inferred 
from developmental and behavioral cues. In cas-
es in which a surgical treatment is planned and 
the clinical picture tends toward a medium-severe 
form, a severity balance must be defined by PSG 
or cardiorespiratory monitoring: in fact, the risk 
profile of postoperative complications is deter-
mined by the degree of severity of the OSA and 
the presence of preoperative comorbidities. The 
degree of severity must be defined by PSG or car-
diorespiratory monitoring because the specificity 
of the questionnaires is equal to 100 for generic 
diagnosis of SDB but not for OSA, thus pulse ox-
imetry may be a useful screening method 8,9. In 
recent years, OSA patients have been observed to 
show elevated inflammatory protein levels (C-re-
active protein, interleukin 10, interleukin 6, fibrin-
ogen, leukotrienes) proportional to the degree of 
severity; this preliminary evidence, if confirmed, 
may represent a low-cost valid test 10. The objec-
tive of this review article is to evaluate the role of 
the otorhinolaryngologist in pediatric OSA.
Materials and Methods
A literature review has been performed on ar-
ticles retrieved from PubMed and Scopus from the 
last 30 years on the following topics: peculiarities 
of sleep-disordered breathing in pediatric age; 
discrimination of sleep disorders; adenotonsillar 
hypertrophy; surgical techniques; adjuvant surgi-
cal procedures.
Results
The Role of the Otorhinolaryngologist
The otolaryngologic clinical examination in-
cludes the oropharyngoscopy, which aims at eval-
uating the tonsillar volume, the space occupied by 
the tongue and the residual respiratory space, and 
a fibroscopy with flexible optics to evaluate the 
degree of collapsibility on the retropalatal and ret-
rolingual level and the consequent degree of ob-
struction. However, it is necessary to consider the 
difficulty in performing a dynamic endoscopic 
examination in children. This may be a sufficient 
reason, especially in cases of medium-severe 
grade, to plan a preoperative drug-induced seda-
tion endoscopy (DISE), also known as sleep-en-
doscopy. It is important to remember that the pres-
ence of tonsillar hypertrophy plays a major role in 
OSA in otherwise healthy children. On the other 
hand, tonsillar hypertrophy is non-determinant 
when there is a neuromuscular deficit, obesity or 
age under two years. These factors are themselves 
causes of persistence of apnea after adenotonsil-
lectomy. It is widely accepted that isolated adenoid 
hypertrophy is not sufficient to determine apnea, 
but it can cause worsening in children at risk 11. In 
addition, the objective examination must always 
evaluate the possible presence of reduced weight 
growth, or obesity; hyperactivity, restlessness, 
learning difficulty; right ventricular hypertrophy, 
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pulmonary hypertension; allergy and/or asthma; 
and neuromuscular disorders, syndromic states, 
mucopolysaccharidosis. These conditions are to 
be considered predictive factors for postoperative 
complications. Surgical removal of the tonsils and 
adenoids is considered the first-line treatment for 
OSA in otherwise healthy children over two years 
of age with adenotonsillar hypertrophy, as recom-
mended by the American Academy of Pediatrics, 
the American Academy of Otolaryngology-Head 
and Neck Surgery and Italian guidelines from the 
Otolaryngology and Pediatrics Societies. Litera-
ture data demonstrates, in mild forms of OSA, a 
complete normalization of PSG data and quality of 
life after adenotonsillectomy. In these patients, al-
ternatives to in-laboratory PSG are possible, such 
as “nap” PSG, overnight continuous pulse oxim-
etry, or audio and video monitoring. However, all 
of these tests have a low negative predictive value; 
a negative result is insufficient to exclude OSA 12. 
The possible complications related to the surgi-
cal procedure itself overlap with those found for 
adenotonsillectomy surgery performed for other 
indications. Significant increase in anesthesiolog-
ical complications in the induction phase and in 
the phase of awakening is related to the severity 
of OSA or the presence of predictive factors (un-
der 2 years of age, underweight, obesity, allergy, 
asthma, cardiorespiratory impairment, apnea hy-
popnea index (AHI) > 10/h, SaO2 nadir < 70). The 
percentage of minor postoperative respiratory 
complications (desaturation < 90%, increased re-
spiratory effort, laryngospasm, asthmatic crisis) 
varies between 16 and 27%. In contrast, with the 
presence of severe OSA, neuromuscular disorders 
or craniofacial malformations 1-15% of children 
have severe respiratory complications (desatura-
tion < 8.0%, pleural effusion, pneumothorax, pul-
monary hypertensive crisis) 13. In these patients 
the intervention must be performed in hospitals 
that have intensive pediatric care. The purpose 
of PSG in these children is to improve diagnos-
tic accuracy in high-risk populations and define 
the severity of OSA to optimize perioperative and 
postoperative planning. 
Surgical Techniques
A variety of instruments have been devised for 
the removal of tonsillar and adenoid tissue. Tra-
ditionally, the most common approach has been 
extracapsular (complete) tonsillectomy, but intra-
capsular (partial) tonsillectomy is increasingly 
used. Extracapsular tonsillectomy (also known 
as complete, total, or sub-capsular tonsillectomy) 
consists of removal of the entire palatine tonsil 
and the surrounding fascia or capsule with ei-
ther cold or hot techniques. For “cold” or sharp 
dissection, the mucosa is sharply excised from 
the tonsillar pillar with a scissor or scalpel, and 
blunt instruments are used to divide the tonsillar 
capsule from the underlying musculature. He-
mostasis is then achieved with a combination of 
pressure, cautery, ligation, or hemostatic agents. 
For “hot” techniques, electrosurgical or thermal 
instruments are utilized to excise the tonsillar 
tissue. A variety of instruments and technologies 
have been developed for this purpose including 
lasers, diathermy, bipolar electrosurgical scissors 
or forceps, and bipolar radiofrequency ionic dis-
sociation. Each of these approaches has advantag-
es. Hot techniques allow for simultaneous cauter-
ization of blood vessels and enable surgeons to 
perform the procedure, in most cases, quickly 
and with minimal blood loss. Cold dissection 
and radiofrequency techniques are associated 
in some studies with less pain and more rapid 
return to normal function. None of the more cur-
rent clinical guidelines advocate for use of any 
one specific surgical technique for extracapsu-
lar tonsillectomy over others, and the decision 
of which technique to use is generally based on 
surgeon preference and training 14. Intracapsular 
tonsillectomy (also known as subtotal or partial 
tonsillectomy, or “tonsillotomy”) is increasing-
ly used for the treatment of obstructive SDB. In 
this technique, microdebriders, bipolar electro-
surgical scissors, or radiofrequency ablation (in-
cluding “coblation”) devices are used to debulk 
the obstructing portions of the tonsil parenchy-
ma 15. Some evidence suggests that the technique 
permits more rapid recovery compared with 
traditional tonsillectomy, and possibly reduces 
the risk of postoperative hemorrhage. However, 
there is a risk of tonsillar regrowth, which usu-
ally is clinically insignificant but occasionally re-
quires revisional surgery. Both extracapsular and 
intracapsular tonsillectomy are effective modali-
ties to treat OSA, with comparable surgical out-
comes on short-term follow-up. However, when 
comorbid diagnoses of both asthma and obesity 
exist, OSA is likely to be refractory to treatment 
with intracapsular compared with extracapsular 
tonsillectomy 16. Adenoidectomy consists in the 
removal of the obstructing portions of adenoid 
tissue from the nasopharynx with the use of either 
sharp curettes (sharp or cold dissection), electro-
cautery, coblation, or microdebrider. The proce-
dure is generally done transorally after retraction 
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of the soft palate, taking care to avoid trauma 
to the undersurface of the palate or Eustachian 
tube orifices. Occasionally, tissue removal via a 
trans-nasal approach may also be necessary. 
Adjuvant Surgical Procedures 
Surgical procedures other than adenotonsillec-
tomy are sometimes considered to treat OSA in 
children without significant tonsillar hypertrophy, 
or with residual disease after adenotonsillectomy. 
These adjuvant surgical procedures may also be 
beneficial in patients with a high probability that 
OSA is due to factors other than adenotonsillar 
hypertrophy alone, such as in children with obe-
sity, Down syndrome, craniofacial syndromes, or 
neuromuscular disease. They include tongue base 
procedures and expansion pharyngoplasty and 
lateral pharyngoplasty.
Airway obstruction at the level of the base of 
the tongue is increasingly recognized as a cause 
of persistent OSA after adenotonsillectomy, 
especially in children with obesity, Down syn-
drome, and craniofacial or neuromuscular dis-
orders 17. Endoscopic-assisted coblation lingual 
tonsillectomy and robotic surgery are the most 
used techniques for a volumetric reduction of the 
tongue base.
In some children, OSA is associated with col-
lapse of the lateral pharyngeal wall. Surgical pro-
cedures to correct this problem include expansion 
sphincter pharyngoplasty or lateral pharyngoplas-
ty. 
Discussion
The otorhinolaryngologist has a central role 
in the diagnosis and treatment of pediatric OSA. 
The diagnostic role is essential for the evaluation 
of the upper airways and of biometric and poly-
somnographic data, while the treatment can rely 
on medical therapies or surgical approach. 
In the majority of healthy children, ade-
notonsillectomy for OSA results in a dramatic 
improvement in respiratory parameters as mea-
sured by polysomnography. There is moderately 
good evidence that adenotonsillectomy improves 
quality of life in children with OSA 18 and there is 
somewhat weaker evidence that adenotonsillecto-
my may improve cognitive function and behavior 
in children with OSA. Observational studies have 
reported postoperative improvements in objective 
measures of impulsivity, inattention, and cogni-
tive function after adenotonsillectomy 19. 
DISE is used for the definition and management 
of patients with residual OSA after adenotonsillecto-
my. Even though the first work published in the liter-
ature on sleep endoscopy by Croft et al20 in 1990 is 
on children, even today DISE has not found a com-
plete, precise, and commonly accepted codification 
in patients of pediatric age 21, both as regards the an-
esthetic protocol and in which cases to carry it out. 
Regarding the drugs to be used, since some of the 
children do not tolerate venous access, the initial use 
of inhalation anesthetics (halothane or sevoflurane) 
is a confusing factor for pediatric DISE because it 
alters the pharyngeal muscle tone. 
The drugs used in DISE in children are propo-
fol, dexmedetomidine (not approved by the Food 
and Drug Administration for pediatric use in the 
United States), ketamine with glycopyrrolate to 
reduce secretions and tachycardia, remifentanil 
and midazolam.
DISE evaluates the extent and orientation of 
obstruction at four to five anatomical sites of po-
tential collapse (adenoids, palate or velum, lateral 
pharyngeal wall, tongue base, and epiglottis or 
supraglottis) 22.
A recent systematic review of the literature 
examined the scoring systems used to report the 
results of DISE in both pediatric and adult age. 
Among the 21 staging methods, the most used 
is Velum oropharynx tongue base epiglottis 
(VOTE), followed by the Pringle and Croft Clas-
sification 23. Vicini in 2012 published a classifi-
cation termed “Nose Oropharynx Hypopharynx 
and Larynx” (NOHL), using a system similar to 
the TNM staging for neoplasms. This classifica-
tion, respecting the objectives of the DISE, takes 
into consideration the obstructive site and the 
degree and pattern of obstruction 24. A system-
atic review on the use of pediatric DISE in 2016 
25 concludes that DISE does not modify decisions 
in cases of significant adenotonsillar hypertrophy 
but should be used in cases where there is per-
sistence of apnea after adenotonsillectomy. How-
ever, many children have residual OSA following 
adenotonsillectomy, as determined through PSG. 
Identification of a biomarker of residual disease 
would be clinically meaningful to detect children 
at risk. Bhattacharjee et al26 have shown that the 
serum high-sensitivity C-reactive protein is an 
inflammatory biomarker, predictive of residu-
al OSA after adenotonsillectomy. Resolution of 
OSA after adenotonsillectomy (post-AT) was de-
fined by a post-AT AHI < 1.5/h. The residual OSA 
was defined as an AHI post-AT > 5/h, which is 
considered to be clinically significant.
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Conclusions
Otolaryngologic assessment is of paramount 
importance to correctly classify a child with 
OSA. Correct inspection of the upper airway and 
quantification of the quality of sleep through poly-
somnography lead to the right therapeutic choice. 
Knowledge of different surgical techniques helps 
to deal with residual OSA after studying the ob-
struction sites by DISE.
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